Validation Digital Bio-markers During Sulforaphane Treatment.

Part of paid clinical trials in Piscataway, New Jersey.

Sponsor
Rutgers, The State University of New Jersey
Study ID
NCT04805957
Status
Enrolling By Invitation

Conditions

Eligibility Criteria

Sex
MALE
Age
13 Years - 30 Years
Healthy Volunteers
Not accepted

Interventions

  • Sulforaphane — DIETARY_SUPPLEMENT
    Sulforaphane comes from eating certain cruciferous vegetables. In this case the pills are made from broccoli seeds.

Study Details

The purpose of the research is to determine if changes seen during sulforaphane treatment (a compound that comes from eating certain vegetables) can better be understood using digital biomarkers. These digital biomarkers are things like heart rate, muscle movement etc. and are measured using non-invasive devices (like a watch) and are aimed at complementing the traditional clinical scores already in use in current trials (e.g. Aberrant Behavior Checklist (ABC), Social Responsiveness Scale (SRS) and Ohio Autism Clinical Impressions Scale (OACIS)).

Key Dates

Start date
Jul 7, 2022
Status verified
Oct 2025
Primary completion
Dec 1, 2026
Completion
Jun 1, 2027

Study Design

Enrollment
10 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Treatment
    All subjects will receive 1.47umol/kg/day sulforaphane for 12 weeks. Pills are taken once a say with a meal.

Primary Outcome Measure

Aberrant Behavior Checklist (ABC) [ Time Frame: Baseline. ]

Locations (1)

FacilityCityStateZIPSite coordinators
Rutgers-RWJMS Department of NeurologyPiscatawayNew Jersey08854-

Find similar trials in Piscataway, NJ

By condition
Autism spectrum disorder
By specialty
Pediatrics
By research site
Rutgers-RWJMS Department of Neurology· Piscataway, NJ

Related Studies